GS0051: Pharmaceuticals and biologics for use in the treatment of genetic disorders, cancer, hematologic disorders, endocrine disorders, reproductive dysfunction, short stature, diabetes, metabolic disorders, disorders of the central nervous system, gastrointestinal disorders, cardiovascular disorders, autoimmune disorders and other disorders of the immune system, infectious diseases and enzyme deficiency diseases; genetically altered cells and cell lines for use in the production of human therapeutic proteins, for medical diagnostic use, for use in the treatment of a variety of diseases and disorders and for implantation into human patients
GS0421: Product research and development services for others in the field of pharmaceuticals and biologics; consulting services in the field of pharmaceutical and biologic production methods, and in the field of clinical protocols for pharmaceuticals and biologics; scientific research services; health care services; diagnostic and genetic medical testing services; medical patient monitoring services; providing information to others about pharmaceuticals, biologics and health care; intellectual property licensing services in the field of pharmaceuticals and biologics
Case File Event Statements
1/7/2004 - 20 years ago
5 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEType:ABN2
5/9/2003 - 21 years ago
4 - NON-FINAL ACTION E-MAILEDType:GNRT
5/8/2003 - 21 years ago
3 - PREVIOUS ALLOWANCE COUNT WITHDRAWNType:ZZZX
1/21/2003 - 21 years ago
2 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA